Affordable Access

Publisher Website

EDG receptors as a potential therapeutic target in retinal ischemia–reperfusion injury

Brain Research
Publication Date
DOI: 10.1016/j.brainres.2006.05.060
  • Ischemia
  • Apoptosis
  • Neuroprotection
  • Retina
  • Lysophosphatidic Acid
  • Biology
  • Medicine


Abstract LPA (lysophosphatidic acid) specific endothelial differentiation gene (EDG) receptors have been implicated in various anti-apoptotic pathways. Ischemia of the brain and retina causes neuronal apoptosis, which raises the possibility that EDG receptors participate in anti-apoptotic signaling in ischemic injury. We examined the expression of EDG receptors in a model of retinal ischemia–reperfusion injury and also tested LXR-1035, a novel analogue of LPA, in the rat following global retinal ischemic injury. Rats were subjected to 45 or 60 min of raised intraocular pressure. Animals were sacrificed at 24 h post-ischemia and retinal tissue was stained for EDG receptors. In separate experiments, animals were randomized to receive LXR or saline vehicle by intravitreal injection 24 h prior to ischemia. The degree of retinal damage was assessed morphologically by measuring the thickness of the inner retinal layers as well as functionally by electroretinography (ERG). We found that the normal retina has a baseline expression of the LPA receptors, EDG-2 and EDG-4, which are significantly upregulated in the inner layers in response to ischemia. Animals pretreated with LXR-1035 had dose-dependent, significant reductions in histopathologic damage and significant improvement in functional deficits compared with corresponding vehicle-controls, after 45 and 60 min of ischemia. These results suggest that LPA receptor signaling may play an important role in neuroprotection in retinal ischemia–reperfusion injury.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Toll-like receptors in liver ischemia reperfusion...

on Expert Opinion on Therapeutic... April 2009

HMGB1: a potential therapeutic target for myocardi...

on International Journal of Cardi... Mar 22, 2012

On the edge: targeting Toll-like receptor 2 in isc...

on Circulation. Cardiovascular in... April 2012
More articles like this..